- Home
- INTS vs MTR Comparison
INTS vs MTR Comparison
Compare INTS & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- MTR
- Stock Information
- Founded
- INTS 2012
- MTR 1979
- Country
- INTS United States
- MTR United States
- Employees
- INTS N/A
- MTR N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- INTS Health Care
- MTR Energy
- Exchange
- INTS Nasdaq
- MTR Nasdaq
- Market Cap
- INTS 10.9M
- MTR 10.9M
- IPO Year
- INTS 2023
- MTR N/A
- Fundamental
- Price
- INTS $0.23
- MTR $5.56
- Analyst Decision
- INTS Strong Buy
- MTR
- Analyst Count
- INTS 4
- MTR 0
- Target Price
- INTS $4.50
- MTR N/A
- AVG Volume (30 Days)
- INTS 4.0M
- MTR 3.4K
- Earning Date
- INTS 11-12-2025
- MTR 01-01-0001
- Dividend Yield
- INTS N/A
- MTR 3.79%
- EPS Growth
- INTS N/A
- MTR N/A
- EPS
- INTS N/A
- MTR 0.21
- Revenue
- INTS N/A
- MTR $580,337.00
- Revenue This Year
- INTS N/A
- MTR N/A
- Revenue Next Year
- INTS N/A
- MTR N/A
- P/E Ratio
- INTS N/A
- MTR $26.29
- Revenue Growth
- INTS N/A
- MTR N/A
- 52 Week Low
- INTS $0.19
- MTR $4.70
- 52 Week High
- INTS $4.30
- MTR $10.42
- Technical
- Relative Strength Index (RSI)
- INTS 32.86
- MTR 47.74
- Support Level
- INTS $0.27
- MTR $5.51
- Resistance Level
- INTS $0.30
- MTR $5.70
- Average True Range (ATR)
- INTS 0.02
- MTR 0.08
- MACD
- INTS -0.00
- MTR 0.00
- Stochastic Oscillator
- INTS 6.39
- MTR 54.84
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.